For patients with NSCLC-SqCC, mutations in the fibroblast growth factor receptor (FGFR1) gene, Erb-B2 Receptor Tyrosine Kinase 2 (ErbB) gene, and TP53 gene have been found [66]. Here, EGFR is linked to non-small cell lung carcinoma.